Listed

Carlsmed, Inc.

CARLNasdaqCIK 1794546HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$18.9mRevenue, Q2 FY2026, three months to 2026-06-30$18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 5, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$18.9mRevenue, Q2 FY2026, three months to 2026-06-30$18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure+56.7% on a year earlier
  • Gross margin76.8%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $14.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure+3.4 pts on a year earlier
  • Operating margin−58.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure−4.5 pts on a year earlier
  • Net margin−55.5%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure+0.5 pts on a year earlier
  • Diluted EPS−$0.39Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure+73.5% on a year earlier
  • Free cash flow−$7.5mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001794546-26-000016. Derived: 6-month figure less the 3-month figure.Capital expenditure: $121.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001794546-26-000016. Derived: 6-month figure less the 3-month figure.Report this figure−1.5% on a year earlier

Last eight quarters

Full statements
Revenue$18.9mGross margin 76.8%
Diluted EPS−$0.39, Q2 FY2026
Free cash flow−$7.5m, Q2 FY2026
Carlsmed, Inc., key figures for the last eight quarters
Line itemUnitperiod not labelled2024-09-30period not labelled2024-12-31period not labelled2025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m6.6Revenue, period not labelled, three months to 2024-09-30$6.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figure9.4Revenue, period not labelled, three months to 2024-12-31$9.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure10.2Revenue, period not labelled, three months to 2025-03-31$10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure12.1Revenue, Q2 FY2025, three months to 2025-06-30$12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure13.1Revenue, Q3 FY2025, three months to 2025-09-30$13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figure15.2Revenue, Q4 FY2025, three months to 2025-12-31$15.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure16.1Revenue, Q1 FY2026, three months to 2026-03-31$16.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure18.9Revenue, Q2 FY2026, three months to 2026-06-30$18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure
Gross margin%72.8%Gross margin, period not labelled, three months to 2024-09-30. gross profit / revenueGross profit: $4.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Revenue: $6.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figure74.7%Gross margin, period not labelled, three months to 2024-12-31. gross profit / revenueGross profit: $7.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Revenue: $9.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure74.9%Gross margin, period not labelled, three months to 2025-03-31. gross profit / revenueGross profit: $7.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Revenue: $10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure73.4%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $8.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure75.9%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $9.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Revenue: $13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figure76.5%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $11.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Revenue: $15.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure77.1%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $12.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Revenue: $16.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure76.8%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $14.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure
Operating margin%(118.0%)Operating margin, period not labelled, three months to 2024-09-30. operating income / revenueOperating income: −$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Revenue: $6.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figure(49.9%)Operating margin, period not labelled, three months to 2024-12-31. operating income / revenueOperating income: −$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Revenue: $9.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure(56.1%)Operating margin, period not labelled, three months to 2025-03-31. operating income / revenueOperating income: −$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Revenue: $10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure(53.8%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure(69.1%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Revenue: $13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figure(61.4%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Revenue: $15.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure(57.6%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Revenue: $16.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure(58.3%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure
Net margin%(118.6%)Net margin, period not labelled, three months to 2024-09-30. net income / revenueNet income: −$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Revenue: $6.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figure(50.2%)Net margin, period not labelled, three months to 2024-12-31. net income / revenueNet income: −$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Revenue: $9.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure(56.2%)Net margin, period not labelled, three months to 2025-03-31. net income / revenueNet income: −$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure(56.0%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure(65.2%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Revenue: $13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figure(56.8%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Revenue: $15.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure(54.0%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $16.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure(55.5%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Revenue: $18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure
Diluted EPS$ per share(2.06)Diluted EPS, period not labelled, three months to 2024-09-30−$2.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figurenot reported (Diluted EPS not reported)(1.47)Diluted EPS, period not labelled, three months to 2025-03-31−$1.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure(1.47)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure(0.40)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269545.Report this figurenot reported (Diluted EPS not reported)(0.32)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure(0.39)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001794546-26-000016.Report this figure
Free cash flow$m(7.6)Free cash flow, period not labelled, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269545. Derived: 9-month figure less the 6-month figure.Capital expenditure: $52.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269545. Derived: 9-month figure less the 6-month figure.Report this figure(4.3)Free cash flow, period not labelled, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Capital expenditure: $61.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Free cash flow, period not labelled, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Capital expenditure: $83.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure(7.4)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001794546-26-000016. Derived: 6-month figure less the 3-month figure.Capital expenditure: $327.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001794546-26-000016. Derived: 6-month figure less the 3-month figure.Report this figure(8.6)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$8.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269545. Derived: 9-month figure less the 6-month figure.Capital expenditure: $159.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269545. Derived: 9-month figure less the 6-month figure.Report this figure(5.4)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Capital expenditure: $73.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071551. Derived: 12-month figure less the 9-month figure.Report this figure(13.1)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Capital expenditure: $79.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001794546-26-000011.Report this figure(7.5)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001794546-26-000016. Derived: 6-month figure less the 3-month figure.Capital expenditure: $121.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001794546-26-000016. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$50.5mGross margin 75.3%
Diluted EPS−$2.12, FY2025
Free cash flow−$29.6m, FY2025
Carlsmed, Inc., key figures for the last five fiscal years
Line itemUnitFY2024-12-31FY20252025-12-31Shape over the periods
Revenue$m27.2Revenue, period not labelled, twelve months to 2024-12-31$27.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure50.5Revenue, FY2025, twelve months to 2025-12-31$50.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure
Gross margin%73.8%Gross margin, period not labelled, twelve months to 2024-12-31. gross profit / revenueGross profit: $20.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001193125-26-071551.Revenue: $27.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure75.3%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $38.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001193125-26-071551.Revenue: $50.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure
Operating margin%(88.8%)Operating margin, period not labelled, twelve months to 2024-12-31. operating income / revenueOperating income: −$24.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071551.Revenue: $27.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure(60.5%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$30.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071551.Revenue: $50.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure
Net margin%(89.3%)Net margin, period not labelled, twelve months to 2024-12-31. net income / revenueNet income: −$24.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071551.Revenue: $27.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure(58.7%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$29.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071551.Revenue: $50.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure
Diluted EPS$ per share(6.11)Diluted EPS, period not labelled, twelve months to 2024-12-31−$6.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure(2.12)Diluted EPS, FY2025, twelve months to 2025-12-31−$2.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure
Free cash flow$m(25.6)Free cash flow, period not labelled, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$25.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071551.Capital expenditure: $180.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure(29.6)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$29.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071551.Capital expenditure: $642.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071551.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Carlsmed, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Jupiter Topco LLC2026-06-30$13.0m1,251,616Not compared
JANUS HENDERSON GROUP PLC2026-03-31$11.1m1,227,452Not compared
Parkman Healthcare Partners LLC2026-06-30$6.2m597,318Added+76,195
BlackRock, Inc.2026-06-30$5.5m532,593Added+85,701
KCM Capital Inc2026-06-30$4.6m440,000Added+240,000
Pier Capital, LLC2026-06-30$3.9m373,677New+373,677
MILLENNIUM MANAGEMENT LLC2026-06-30$3.1m295,907New+295,907
Palumbo Wealth Management LLC2026-06-30$2.8m267,298New+267,298
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$2.5m238,727Reduced−37,404
Schonfeld Strategic Advisors LLC2026-06-30$2.3m224,804Reduced−58,376

Recent filings

All 93 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Carlsmed, Inc., recent filings
FiledFormWhat it isAccession number
2026-09-3009:15 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001794546-26-000020
2026-09-0816:06 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001794546-26-000018
2026-08-0516:10 ET10-QQuarterly reportPeriod 2026-06-300001794546-26-000016
2026-08-0516:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001794546-26-000015
2026-06-0316:05 ET8-K5.07 Shareholder vote results0001193125-26-255404
2026-05-0516:10 ET10-QQuarterly reportPeriod 2026-03-310001794546-26-000011
2026-05-0516:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001794546-26-000010
2026-04-2208:30 ETDEF 14AProxy statementPeriod 2026-06-030001794546-26-000005
2026-02-2516:09 ET10-KAnnual reportPeriod 2025-12-310001193125-26-071551
2026-02-2516:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-071512

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1794546
Tickers
CARL
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 09:38 ET. Listed shows no prices and gives no investment advice.